Sheng Fan

发表

Estrogen promotes the metastasis of non‑small cell lung cancer via estrogen receptor β by upregulation of Toll‑like receptor 4 and activation of the myd88/NF‑κB/MMP2 pathway.

Huifang Liang, Dong Li, Sheng Zhou, 2020, Oncology reports.

Estrogen receptor β1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer.

Q. Chu, Xiangning Fu, S. Fu, 2018, Oncology reports.

17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression

Xiao Wei, Changyu Liu, Y. Liao, 2018, Journal of Experimental & Clinical Cancer Research.

Estrogen promotes tumor metastasis via estrogen receptor beta-mediated regulation of matrix-metalloproteinase-2 in non-small cell lung cancer

Sheng Zhou, Changyu Liu, Y. Liao, 2017, Oncotarget.

G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1

Bo Zhou, Sheng Zhou, Jianmiao Wang, 2015, Medical Oncology.

17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression

Changyu Liu, Y. Liao, B. Ai, 2018, Journal of experimental & clinical cancer research : CR.

G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer.

Sheng Zhou, Jianmiao Wang, Xiangning Fu, 2019, Oncology research.

Estrogen promotes tumor metastasis via estrogen receptor beta-mediated regulation of matrix-metalloproteinase-2 in non-small cell lung cancer

Sheng Zhou, Changyu Liu, Y. Liao, 2017, OncoTarget.

Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer

D. Li, X. Cao, Lequn Li, 2019, Clinical and Translational Oncology.